Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer

Fei Mao; Jing-jing Kang; Xiu Cai; Ning-feng Ding; Yun-bing Wu; Yong-min Yan; Hui Qian; Xu Zhang; Wen-rong Xu

doi:10.5114/wo.2017.68616

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

2/2017
vol. 21

Send email

Copy url:

abstract:

Original paper

Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer

Fei Mao

,

Jing-jing Kang

,

Xiu Cai

,

Ning-feng Ding

,

Yun-bing Wu

,

Yong-min Yan

,

Hui Qian

,

Xu Zhang

,

Wen-rong Xu

Contemp Oncol (Pozn) 2017; 21 (2): 91–97

DOI: https://doi.org/10.5114/wo.2017.68616

Online publish date: 2017/06/30

View full text Get citation

PlumX metrics:

Mesenchymal stem cells (MSCs) are attractive seed cells for immunotherapy, tissue engineering and regenerative medicine due to their self-renewal and multidirectional differentiation abilities, diverse immunoregulatory functions and ease of isolation from a wide range of tissues. MSCs exert their immunoregulatory effect on immune cells via cell-to-cell contact and paracrine mechanisms. In turn, MSCs can also be modulated by immune cells. Macrophages are constantly present in the mucosa of the intestinal tract of mammals and play an important role in the development and progression of inflammatory bowel disease (IBD), a chronic and recurrent inflammatory disease of the gastrointestinal tract characterized by idiopathic mucosal inflammation. The increased morbidity and mortality of IBD have made it a disease hard to cure in the clinic. MSCs have emerged as an important tool for IBD therapy due to their abilities to differentiate into enterocyte-like cells and regulate inflammatory cells, especially macrophages. In this review, we discuss the recent advances in the interaction between MSCs and macrophages in diseases, with an emphasis on IBD. We propose that an optimized MSC-based therapy would provide a novel strategy for the treatment of IBD and the prevention of IBD-associated colorectal cancer (CRC).

keywords:

Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer

Fei Mao , Jing-jing Kang , Xiu Cai , Ning-feng Ding , Yun-bing Wu , Yong-min Yan , Hui Qian , Xu Zhang , Wen-rong Xu

mesenchymal stem cell, inflammatory bowel disease, macrophage, immunoregulatory, colorectal cancer

Fei Mao

,

Jing-jing Kang

,

Xiu Cai

,

Ning-feng Ding

,

Yun-bing Wu

,

Yong-min Yan

,

Hui Qian

,

Xu Zhang

,

Wen-rong Xu